Report Detail
Global (United States, European Union and China) Pneumococcal Vaccines Market Research Report 2019-2025
- RnM3461120 |
- 27 May, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Pneumococcal Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pneumococcal Vaccines.
This report studies the global market size of Pneumococcal Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pneumococcal Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
Market Segment by Product Type
PPSV 23
PCV 7/13
PCV 10
Market Segment by Application
For Infants
For Children (2-10)
For Person (10-64)
For The Old (≥65)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pneumococcal Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pneumococcal Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pneumococcal Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pneumococcal Vaccines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 PPSV 23
- 1.3.3 PCV 7/13
- 1.3.4 PCV 10
- 1.4 Market Segment by Application
- 1.4.1 Global Pneumococcal Vaccines Market Share by Application (2019-2025)
- 1.4.2 For Infants
- 1.4.3 For Children (2-10)
- 1.4.4 For Person (10-64)
- 1.4.5 For The Old (≥65)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pneumococcal Vaccines Market Size
- 2.1.1 Global Pneumococcal Vaccines Revenue 2014-2025
- 2.1.2 Global Pneumococcal Vaccines Sales 2014-2025
- 2.2 Pneumococcal Vaccines Growth Rate by Regions
- 2.2.1 Global Pneumococcal Vaccines Sales by Regions 2014-2019
- 2.2.2 Global Pneumococcal Vaccines Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Pneumococcal Vaccines Sales by Manufacturers
- 3.1.1 Pneumococcal Vaccines Sales by Manufacturers 2014-2019
- 3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.3 Pneumococcal Vaccines Price by Manufacturers
- 3.4 Key Manufacturers Pneumococcal Vaccines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pneumococcal Vaccines Market
- 3.6 Key Manufacturers Pneumococcal Vaccines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 PPSV 23 Sales and Revenue (2014-2019)
- 4.1.2 PCV 7/13 Sales and Revenue (2014-2019)
- 4.1.3 PCV 10 Sales and Revenue (2014-2019)
- 4.2 Global Pneumococcal Vaccines Sales Market Share by Type
- 4.3 Global Pneumococcal Vaccines Revenue Market Share by Type
- 4.4 Pneumococcal Vaccines Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pneumococcal Vaccines Sales by Application
6 United States
- 6.1 United States Pneumococcal Vaccines Breakdown Data by Company
- 6.2 United States Pneumococcal Vaccines Breakdown Data by Type
- 6.3 United States Pneumococcal Vaccines Breakdown Data by Application
7 European Union
- 7.1 European Union Pneumococcal Vaccines Breakdown Data by Company
- 7.2 European Union Pneumococcal Vaccines Breakdown Data by Type
- 7.3 European Union Pneumococcal Vaccines Breakdown Data by Application
8 China
- 8.1 China Pneumococcal Vaccines Breakdown Data by Company
- 8.2 China Pneumococcal Vaccines Breakdown Data by Type
- 8.3 China Pneumococcal Vaccines Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Pneumococcal Vaccines Breakdown Data by Company
- 9.2 Rest of World Pneumococcal Vaccines Breakdown Data by Type
- 9.3 Rest of World Pneumococcal Vaccines Breakdown Data by Application
- 9.4 Rest of World Pneumococcal Vaccines Breakdown Data by Countries
- 9.4.1 Rest of World Pneumococcal Vaccines Sales by Countries
- 9.4.2 Rest of World Pneumococcal Vaccines Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Pfizer
- 10.1.1 Pfizer Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.1.4 Pneumococcal Vaccines Product Introduction
- 10.1.5 Pfizer Recent Development
- 10.2 Sanofi
- 10.2.1 Sanofi Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.2.4 Pneumococcal Vaccines Product Introduction
- 10.2.5 Sanofi Recent Development
- 10.3 GSK
- 10.3.1 GSK Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.3.4 Pneumococcal Vaccines Product Introduction
- 10.3.5 GSK Recent Development
- 10.4 Merck
- 10.4.1 Merck Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.4.4 Pneumococcal Vaccines Product Introduction
- 10.4.5 Merck Recent Development
- 10.5 Eli Lilly
- 10.5.1 Eli Lilly Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.5.4 Pneumococcal Vaccines Product Introduction
- 10.5.5 Eli Lilly Recent Development
- 10.6 AstraZeneca
- 10.6.1 AstraZeneca Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.6.4 Pneumococcal Vaccines Product Introduction
- 10.6.5 AstraZeneca Recent Development
- 10.7 Abera
- 10.7.1 Abera Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.7.4 Pneumococcal Vaccines Product Introduction
- 10.7.5 Abera Recent Development
- 10.8 S K Chemicals
- 10.8.1 S K Chemicals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.8.4 Pneumococcal Vaccines Product Introduction
- 10.8.5 S K Chemicals Recent Development
- 10.9 Beijing Minhai Biotechnology
- 10.9.1 Beijing Minhai Biotechnology Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.9.4 Pneumococcal Vaccines Product Introduction
- 10.9.5 Beijing Minhai Biotechnology Recent Development
- 10.10 Baxter
- 10.10.1 Baxter Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Pneumococcal Vaccines
- 10.10.4 Pneumococcal Vaccines Product Introduction
- 10.10.5 Baxter Recent Development
- 10.11 Biken
- 10.12 Celgene Corporation
- 10.13 Panacea Biotec
- 10.14 Serum Institute of India
- 10.15 Genentech
- 10.16 Genocea Biosciences
- 10.17 ImmunoBiology
- 10.18 Lupin
- 10.19 Nuron Biotech
- 10.20 Biogen
- 10.21 Valneva Austria
- 10.22 Sinovac
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pneumococcal Vaccines Sales Channels
- 11.2.2 Pneumococcal Vaccines Distributors
- 11.3 Pneumococcal Vaccines Customers
12 Market Forecast
- 12.1 Global Pneumococcal Vaccines Sales and Revenue Forecast 2019-2025
- 12.2 Global Pneumococcal Vaccines Sales Forecast by Type
- 12.3 Global Pneumococcal Vaccines Sales Forecast by Application
- 12.4 Pneumococcal Vaccines Forecast by Regions
- 12.4.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2019-2025
- 12.4.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pneumococcal Vaccines . Industry analysis & Market Report on Pneumococcal Vaccines is a syndicated market report, published as Global (United States, European Union and China) Pneumococcal Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pneumococcal Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
